trending Market Intelligence /marketintelligence/en/news-insights/trending/7Cjwc6IstdwxhxJWi6XqsA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

J&J unit sued in the UK for allegedly selling faulty hip implants

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

J&J unit sued in the UK for allegedly selling faulty hip implants

DePuy International Ltd., a unit of Johnson & Johnson, is being sued for selling faulty hip implants in the U.K., Bloomberg News reported Oct. 16.

The lawsuit alleges that the implants released metal particles into the body causing multiple health issues, the news outlet reported, citing lawyers for the 341 claimants in the case.

The first stage of the lawsuit will determine the liability of DePuy, and if the claims are proven there will be more court hearings to decide the compensation to be paid.

Depuy's lawyers responded to the claims by stating that the company was not at fault and "the burden of proving that the product was defective and that the defect caused harm rests on the claimants."

The J&J unit was previously sued in the U.S. where the company was ordered to pay about $500 million in damages.

The company is facing 9,000 lawsuits over marketing the flawed hip implants, which it stopped selling in 2013 after the U.S. Food and Drug Administration tightened regulations on artificial-hip implants.